Company Overview and News

6
GNW / Genworth Financial, Inc. 8-K (Current Report)

2018-10-04 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
GNW

10
Top Ranked Value Stocks to Buy for September 20th

2018-09-20 zacks
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 20th:
WFC WFCNP KNL GNW CAL

6
Top Ranked Value Stocks to Buy for September 17th

2018-09-17 zacks
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 17th:
GPI GNW CAL

6
Top Ranked Value Stocks to Buy for September 14th

2018-09-14 zacks
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 14th:
CY KNL GNW CVTI

8
GNW / Genworth Financial, Inc. 8-K (Current Report)

2018-09-14 sec.gov - 2
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
GNW

7
GNW / Genworth Financial, Inc. 8-K (Current Report)

2018-09-13 sec.gov - 1
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
GNW

6
B. Riley FBR Adds Corporate Restructuring Veteran Alex Rohan as Senior Managing Director

2018-09-12 globenewswire
LOS ANGELES, Sept. 12, 2018 (GLOBE NEWSWIRE) -- B. Riley FBR, Inc. (“B. Riley FBR”), a leading full service investment bank and wholly-owned subsidiary of B. Riley Financial, Inc., announced today that Alex Rohan has joined the firm as a Senior Managing Director in its Corporate Restructuring division. Rohan brings over 25 years of investment banking, legal and financial advisory experience, most of which has involved all aspects of complex corporate restructurings.
RILY GNW

6
Top Ranked Value Stocks to Buy for September 7th

2018-09-07 zacks
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 7th:
KNL GNW CVTI

7
Top Ranked Value Stocks to Buy for September 4th

2018-09-04 zacks
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 4th:
KNL GNW IX

6
Why Is Genworth Financial (GNW) Down 0.9% Since Last Earnings Report?

2018-08-30 zacks
A month has gone by since the last earnings report for Genworth Financial (GNW - Free Report) . Shares have lost about 0.9% in that time frame, underperforming the S&P 500.
AMT GNW

13
Garmin, Cinemark, Netflix, Apple and Amazon highlighted as Zacks Bull and Bear of the Day

2018-08-27 zacks
Chicago, IL – August 27, 2018 – Zacks Equity Research highlights Garmin Ltd. (GRMN - Free Report) as the Bull of the Day, Cinemark Holdings (CNK - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Netflix (NFLX - Free Report) , Apple (AAPL - Free Report) and Amazon (AMZN - Free Report) .
RYAM CVGI ATH GRMN AAPL LXFR NFLX CNK GNW TRTN FG

22
Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.

2018-08-27 zacks
Chicago, IL – August 27, 2018 – Today, Zacks Equity Research discusses Beverages - Alcohol, including Anheuser-Busch InBev SA/NV (BUD - Free Report) , Constellation Brands (STZ - Free Report) , Canopy Growth Corp. (CGC - Free Report) , Heineken (HEINY - Free Report) and Brown-Forman (BF.B - Free Report) .
RYAM CVGI STZ.B BUD ATH LXFR STZ TRTN CGC SAM BF.B WEED AHBIF GNW FG

12
Zacks Investment Ideas feature highlights: Michael Kors, Columbia Sportswear and Ralph Lauren

2018-08-27 zacks
Chicago, IL – August 27, 2018 – Today, Zacks Investment Ideas feature highlights Features: Michael Kors Holdings (KORS - Free Report) , Columbia Sportswear (COLM - Free Report) and Ralph Lauren (RL - Free Report) .
CHOO RYAM CVGI ATH KORS RL LXFR JYMHF GNW TRTN FG

12
Zacks.com featured highlights include: JinkoSolar, Big Lots, Rayonier, ON and PCM

2018-08-27 zacks
Chicago, IL – August 27, 2018 - Stocks in this week’s article are JinkoSolar Holding Co., Ltd. (JKS - Free Report) , Big Lots, Inc. (BIG - Free Report) , Rayonier Advanced Materials Inc. (RYAM - Free Report) , ON Semiconductor Corporation (ON - Free Report) and PCM, Inc. (PCMI - Free Report) .
RYAM CVGI ATH LXFR BIG TRTN GNW ON FG

12
The Zacks Analyst Blog Highlights: Heidrick & Struggles, BG Staffing, Insperity and Kforce

2018-08-27 zacks
Chicago, IL –August 27, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Heidrick & Struggles International, Inc. (HSII - Free Report) , BG Staffing, Inc. (BGSF - Free Report) , Insperity Inc. (NSP - Free Report) and Kforce, Inc.
RYAM CVGI KFRC ATH HSII LXFR NSP TRTN GNW BGSF FG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to GNW / Genworth Financial, Inc. on message board site Silicon Investor.

Cognigen:CGNW Cognigen:CGNW Cognigen:CGNW GNWR: Genesee u0026 Wyoming, Inc. GNWR: Genesee u0026 Wyoming, Inc. GNWR: Genesee u0026 Wyoming, Inc.
UNDERVALUED GEM - GNWR - P.E. = 9 / E.P.S. = 2.20 UNDERVALUED GEM - GNWR - P.E. = 9 / E.P.S. = 2.20 UNDERVALUED GEM - GNWR - P.E. = 9 / E.P.S. = 2.20
CUSIP: 37247D106